PharmaShots | Incisive News in 3 Shots

Subscribe Now

Orphan Drug Designations

Galecto's GB0139 Receives the US FDA's and EMA's Orphan Drug Designations for Idiopathic Pulmonary Fibrosis

Galecto's GB0139 Receives the US FDA's and EMA's Orphan Drug Designations for Idiopathic Pulmonary Fibrosis

August 28, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us